14 November is World Diabetes Day
Noncommunicable Diseases, Rehabilitation and Disability
We are responsible for leading, coordinating and monitoring global action to cover additional people with health services, medicines, vaccines, diagnostic and health technologies for the prevention, screening, early diagnosis and appropriate treatment of cardiovascular diseases, cancers, chronic respiratory diseases and diabetes. We aim to advance health equity for persons with disabilities, we have a focus on sensory impairments and bring together the work on rehabilitation from across the departments and from the 3 levels of the organization.
Diabetes programme
The Diabetes programme, named The WHO Global Diabetes Compact, has the vision of reducing the risk of diabetes, and ensuring that all people who are diagnosed with diabetes have access to equitable, comprehensive, affordable and quality treatment and care.
Coverage targets
There are 5 global coverage targets for diabetes to be achieved by 2030:
- 80% of people with diabetes are diagnosed;
- 80% of people with diagnosed diabetes have good control of glycaemia;
- 80% of people with diagnosed diabetes have good control of blood pressure;
- 60% of people with diabetes of 40 years or older receive statins; and
- 100% of people with type 1 diabetes have access to affordable insulin and blood glucose self-monitoring.
Workstreams
The Global Diabetes Compact works through 6 workstreams to advance the diabetes agenda and accelerate progress towards the global coverage targets:
- access to essential diabetes medicines and associated health technologies;
- technical products;
- prevention, health promotion and health literacy;
- country support;
- research and innovation; and
- governance, strategy and partnerships.
Campaigns
Breaking barriers, bridging gaps
Our work
WHO Technical Advisory Group of Experts on Diabetes
Engagement of people living with diabetes
Country profiles
Country profiles
Country profiles present selected data, statistics and information to provide national health profiles at given points in time.
Related publications
All →
18 November 2024
The Global Diabetes Compact: progress in supporting its workstreams: technical report
In 2021, WHO launched the Global Diabetes Compact (GDC), an initiative to reduce the risk of diabetes and ensure that all people who are diagnosed with...
14 November 2024
Guidance on global monitoring for diabetes prevention and control: Framework, indicators and application
The Guidance on global monitoring for diabetes prevention and control by WHO provides a comprehensive framework to support countries in tracking and managing...
10 November 2023
Tobacco and diabetes
This document is the seventh in a series of Tobacco Knowledge Summaries. This document is prepared with the objective to summarize the current evidence...
18 October 2023
The selection and use of essential in vitro diagnostics: report of the fourth meeting of the WHO Strategic...
The Technical report of the fourth meeting of the WHO Strategic Advisory Group of Experts on In Vitro Diagnostics, 2022 (including the fourth WHO model...
3 July 2023
WHO acceleration plan to stop obesity
At the 75th World Health Assembly in 2022, Member States adopted new recommendations for the prevention and management of obesity and endorsed the...
The Assessment package has been developed for countries to evaluate the implementation of the WHO Standards for prosthetics and orthotics. It enables identification...
14 November 2022
Physical activity and sedentary behaviour: a brief to support people living with type 2 diabetes
This brief summarises the recommendations on physical activity and sedentary behaviour for people living with type 2 diabetes. It will support and guide...
13 January 2022
Improving diabetes outcomes for all, a hundred years on from the discovery of insulin
Improving diabetes outcomes for all, a hundred years on from the discovery of insulin: report of the Global Diabetes Summit The Global Diabetes Summit,...
12 November 2021
Keeping the 100-year-old promise: making insulin access universal
The year 2021 marks 100 years since the momentous discovery of insulin in 1921, which marked a turning point in care for those with diabetes. Over the...
30 September 2021
Executive summary: the selection and use of essential medicines 2021: report of the 23rd WHO Expert Committee...
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines...
30 June 2021
WHO list of priority medical devices for management of cardiovascular diseases and diabetes
This publication was developed in response to the need for a reference list of priority medical devices required for management of noncommunicable diseases...
7 September 2020
WHO package of essential noncommunicable (PEN) disease interventions for primary health care
Noncommunicable diseases (NCDs), also known as chronic diseases, tend to be of long duration and are the result of a combination of genetic, physiological,...
22 April 2020
HEARTS D: diagnosis and management of type 2 diabetes
This new HEARTS – D module on Diagnosis and management of type 2 diabetes complements and expands the diabetes section of the HEARTS Technical Package...
21 April 2018
Guidelines on second- and third-line medicines and type of insulin for the control of blood glucose levels...
Diabetes is a chronic, progressive disease characterized by elevated blood glucose levels. Diabetes can lead to complications such as cardiovascular...
27 December 2016
HEARTS: Technical package for cardiovascular disease management in primary health care
High blood pressure kills more people than any other condition – approximately 10 million people each year, more than all infectious diseases combined....
Other technical resources
